High-throughput screening to identify inhibitors of lysine demethylases

References

• Martin C , ZhangY . The diverse functions of histone lysine methylation . Nat. Rev. Mol. Cell. Biol.6 ( 11 ), 838 – 849 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Bremang M , CuomoA , AgrestaAM , StugiewiczM , SpadottoV , BonaldiT . Mass spectrometry-based identification and characterisation of lysine and arginine methylation in the human proteome . Mol. Biosyst.9 ( 9 ), 2231 – 2247 ( 2013 ).
   PubMedGoogle Scholar
• Cao XJ , ArnaudoAM , GarciaBA . Large-scale global identification of protein lysine methylation in vivo . Epigenetics8 ( 5 ), 477 – 485 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Huang J , SenguptaR , EspejoABet al. p53 is regulated by the lysine demethylase LSD1 . Nature449 ( 7158 ), 105 – 108 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Lu T , JacksonMW , SinghiADet al. Validation-based insertional mutagenesis identifies lysine demethylase FBXL11 as a negative regulator of NFkappaB . Proc. Natl Acad. Sci. USA106 ( 38 ), 16339 – 16344 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Lu T , JacksonMW , WangBet al. Regulation of NF-kappaB by NSD1/FBXL11-dependent reversible lysine methylation of p65 . Proc. Natl Acad. Sci. USA107 ( 1 ), 46 – 51 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Kooistra SM , HelinK . Molecular mechanisms and potential functions of histone demethylases . Nat. Rev. Mol. Cell. Biol.13 ( 5 ), 297 – 311 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Shi Y , LanF , MatsonCet al. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1 . Cell119 ( 7 ), 941 – 953 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Tsukada Y , FangJ , Erdjument-BromageHet al. Histone demethylation by a family of JmjC domain-containing proteins . Nature439 ( 7078 ), 811 – 816 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Suzuki T , MiyataN . Lysine demethylases inhibitors . J. Med. Chem.54 ( 24 ), 8236 – 8250 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Hojfeldt JW , AggerK , HelinK . Histone lysine demethylases as targets for anticancer therapy . Nat. Rev. Drug Discov.12 ( 12 ), 917 – 930 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Blair LP , CaoJ , ZouMR , SayeghJ , YanQ . Epigenetic regulation by lysine demethylase 5 (KDM5) enzymes in cancer . Cancers (Basel)3 ( 1 ), 1383 – 1404 ( 2011 ).
   PubMedGoogle Scholar
• De Santa F , TotaroMG , ProsperiniE , NotarbartoloS , TestaG , NatoliG . The histone H3 lysine-27 demethylase Jmjd3 links inflammation to inhibition of polycomb-mediated gene silencing . Cell130 ( 6 ), 1083 – 1094 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Jensen LR , AmendeM , GurokUet al. Mutations in the JARID1C gene, which is involved in transcriptional regulation and chromatin remodeling, cause X-linked mental retardation . Am. J. Hum. Genet.76 ( 2 ), 227 – 236 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Hou H , YuH . Structural insights into histone lysine demethylation . Curr. Opin. Struct. Biol.20 ( 6 ), 739 – 748 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Thinnes CC , EnglandKS , KawamuraA , ChowdhuryR , SchofieldCJ , HopkinsonRJ . Targeting histone lysine demethylases: progress, challenges, and the future . Biochim. Biophys. Acta doi: 10.1016/j.bbagrm.2014.05.009 ( 2014 ) ( Epub ahead of print ).
   PubMed Web of Science ®Google Scholar
• Luo X , LiuY , KubicekSet al. A selective inhibitor and probe of the cellular functions of Jumonji C domain-containing histone demethylases . J. Am. Chem. Soc.133 ( 24 ), 9451 – 9456 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Kruidenier L , ChungCW , ChengZet al. A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response . Nature488 ( 7411 ), 404 – 408 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Sorna V , TheisenER , StephensBet al. High-throughput virtual screening identifies novel N’-(1-phenylethylidene)-benzohydrazides as potent, specific, and reversible LSD1 inhibitors . J. Med. Chem.56 ( 23 ), 9496 – 9508 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Wang J , LuF , RenQet al. Novel histone demethylase LSD1 inhibitors selectively target cancer cells with pluripotent stem cell properties . Cancer Res.71 ( 23 ), 7238 – 7249 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Willmann D , LimS , WetzelSet al. Impairment of prostate cancer cell growth by a selective and reversible lysine-specific demethylase 1 inhibitor . Int. J. Cancer131 ( 11 ), 2704 – 2709 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Zhang JH , ChungTD , OldenburgKR . A simple statistical parameter for use in evaluation and validation of High-throughput screening assays . J. Biomol. Screen.4 ( 2 ), 67 – 73 ( 1999 ).
   PubMed Web of Science ®Google Scholar
• Quinn AM , SimeonovA . Methods for activity analysis of the proteins that regulate histone methylation . Curr. Chem. Genomics5 ( Suppl. 1 ), 95 – 105 ( 2011 ).
   PubMedGoogle Scholar
• Spannhoff A , HauserAT , HeinkeR , SipplW , JungM . The emerging therapeutic potential of histone methyltransferase and demethylase inhibitors . ChemMedChem4 ( 10 ), 1568 – 1582 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Schmitt ML , LadweinKI , CarlinoLet al. Heterogeneous antibody-based activity assay for lysine specific demethylase 1 (LSD1) on a histone peptide substrate . J. Biomol. Screen.19 ( 6 ), 973 – 978 ( 2014 ).
   PubMedGoogle Scholar
• Lizcano JM , UnzetaM , TiptonKF . A spectrophotometric method for determining the oxidative deamination of methylamine by the amine oxidases . Anal. Biochem.286 ( 1 ), 75 – 79 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• King ON , LiXS , SakuraiMet al. Quantitative high-throughput screening identifies 8-hydroxyquinolines as cell-active histone demethylase inhibitors . PLoS ONE5 ( 11 ), e15535 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Hauser AT , BissingerEM , MetzgerEet al. Screening assays for epigenetic targets using native histones as substrates . J. Biomol. Screen.17 ( 1 ), 18 – 26 ( 2012 ).
   PubMedGoogle Scholar
• Sakurai M , RoseNR , SchultzLet al. A miniaturized screen for inhibitors of Jumonji histone demethylases . Mol. Biosyst.6 ( 2 ), 357 – 364 ( 2010 ).
   PubMedGoogle Scholar
• Wang Y , ZhangH , ChenYet al. LSD1 is a subunit of the NuRD complex and targets the metastasis programs in breast cancer . Cell138 ( 4 ), 660 – 672 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Yu W , EramMS , HajianTet al. A scintillation proximity assay for histone demethylases . Anal. Biochem.463 , 54 – 60 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Ullman EF , KirakossianH , SinghSet al. Luminescent oxygen channeling immunoassay: measurement of particle binding kinetics by chemiluminescence . Proc. Natl Acad. Sci. USA91 ( 12 ), 5426 – 5430 ( 1994 ).
   PubMed Web of Science ®Google Scholar
• Kawamura A , TumberA , RoseNRet al. Development of homogeneous luminescence assays for histone demethylase catalysis and binding . Anal. Biochem.404 ( 1 ), 86 – 93 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Sayegh J , CaoJ , ZouMRet al. Identification of small-molecule inhibitors of Jumonji AT-rich interactive domain 1B (JARID1B) histone demethylase by a sensitive High-throughput screen . J. Biol. Chem.288 ( 13 ), 9408 – 9417 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Gauthier N , CaronM , PedroLet al. Development of homogeneous nonradioactive methyltransferase and demethylase assays targeting histone H3 lysine 4 . J. Biomol. Screen.17 ( 1 ), 49 – 58 ( 2012 ).
   PubMedGoogle Scholar
• Wang C , CaronM , BurdickDet al. A sensitive, homogeneous, and high-throughput assay for lysine-specific histone demethylases at the H3K4 site . Assay Drug Dev. Technol.10 ( 2 ), 179 – 186 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Yu V , FischT , LongAMet al. High-throughput TR-FRET assays for identifying inhibitors of LSD1 and JMJD2C histone lysine demethylases . J. Biomol. Screen.17 ( 1 ), 27 – 38 ( 2012 ).
   PubMedGoogle Scholar
• Glickman JF , WuX , MercuriRet al. A comparison of ALPHAScreen, TR-FRET, and TRF as assay methods for FXR nuclear receptors . J. Biomol. Screen.7 ( 1 ), 3 – 10 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Rose NR , WoonEC , KinghamGLet al. Selective inhibitors of the JMJD2 histone demethylases: combined nondenaturing mass spectrometric screening and crystallographic approaches . J. Med. Chem.53 ( 4 ), 1810 – 1818 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Plant M , DineenT , ChengA , LongAM , ChenH , MorgensternKA . Screening for lysine-specific demethylase-1 inhibitors using a label-free high-throughput mass spectrometry assay . Anal. Biochem.419 ( 2 ), 217 – 227 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Hutchinson SE , LeveridgeMV , HeathcoteMLet al. Enabling lead discovery for histone lysine demethylases by high-throughput RapidFire mass spectrometry . J. Biomol. Screen.17 ( 1 ), 39 – 48 ( 2012 ).
   PubMedGoogle Scholar
• Leveridge M , BuxtonR , ArgyrouAet al. Demonstrating enhanced throughput of RapidFire mass spectrometry through multiplexing using the JmjD2d demethylase as a model system . J. Biomol. Screen.19 ( 2 ), 278 – 286 ( 2014 ).
   PubMedGoogle Scholar
• Mulji A , HaslamC , BrownFet al. Configuration of a high-content imaging platform for hit identification and pharmacological assessment of JMJD3 demethylase enzyme inhibitors . J. Biomol. Screen.17 ( 1 ), 108 – 120 ( 2012 ).
   PubMedGoogle Scholar
• Mannironi C , ProiettoM , BufalieriFet al. An high-throughput in vivo screening system to select H3K4-specific histone demethylase inhibitors . PLoS ONE9 ( 1 ), e86002 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Wang L , ChangJ , VargheseDet al. A small-molecule modulates Jumonji histone demethylase activity and selectively inhibits cancer growth . Nat. Commun.4 , 2035 ( 2013 ).
   PubMed Web of Science ®Google Scholar